A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumours
Titel:
A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumours
Auteur:
Dumez, H. Awada, A. Piccart, M. Assadourian, S. Semiond, D. Guetens, G. de Boeck, G. Maes, R.A.A. de Bruijn, E.A. van Oosterom, A.